nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—hypertension—chronic kidney failure	0.511	1	CtDrD
Methyldopa—DDC—chronic kidney failure	0.436	1	CbGaD
Methyldopa—DDC—nerve—chronic kidney failure	0.0025	0.136	CbGeAlD
Methyldopa—DDC—blood plasma—chronic kidney failure	0.00189	0.103	CbGeAlD
Methyldopa—Carbidopa—DDC—chronic kidney failure	0.00128	0.351	CrCbGaD
Methyldopa—COMT—blood plasma—chronic kidney failure	0.00125	0.0678	CbGeAlD
Methyldopa—DDC—nephron tubule—chronic kidney failure	0.000974	0.0529	CbGeAlD
Methyldopa—DDC—renal system—chronic kidney failure	0.000886	0.0481	CbGeAlD
Methyldopa—DDC—kidney—chronic kidney failure	0.000856	0.0465	CbGeAlD
Methyldopa—DDC—cortex of kidney—chronic kidney failure	0.000834	0.0453	CbGeAlD
Methyldopa—SLC15A1—nephron tubule—chronic kidney failure	0.000724	0.0393	CbGeAlD
Methyldopa—SLC15A1—renal system—chronic kidney failure	0.000658	0.0357	CbGeAlD
Methyldopa—COMT—nephron tubule—chronic kidney failure	0.000644	0.035	CbGeAlD
Methyldopa—SLC15A1—kidney—chronic kidney failure	0.000637	0.0346	CbGeAlD
Methyldopa—ADRA2A—blood plasma—chronic kidney failure	0.000636	0.0345	CbGeAlD
Methyldopa—COMT—renal system—chronic kidney failure	0.000586	0.0318	CbGeAlD
Methyldopa—COMT—cardiovascular system—chronic kidney failure	0.000579	0.0314	CbGeAlD
Methyldopa—COMT—urethra—chronic kidney failure	0.000575	0.0312	CbGeAlD
Methyldopa—COMT—kidney—chronic kidney failure	0.000566	0.0307	CbGeAlD
Methyldopa—COMT—cortex of kidney—chronic kidney failure	0.000551	0.0299	CbGeAlD
Methyldopa—SLC15A1—digestive system—chronic kidney failure	0.00054	0.0293	CbGeAlD
Methyldopa—COMT—gonad—chronic kidney failure	0.000525	0.0285	CbGeAlD
Methyldopa—COMT—digestive system—chronic kidney failure	0.00048	0.0261	CbGeAlD
Methyldopa—COMT—blood—chronic kidney failure	0.000458	0.0248	CbGeAlD
Methyldopa—Droxidopa—DDC—chronic kidney failure	0.000425	0.117	CrCbGaD
Methyldopa—L-DOPA—DDC—chronic kidney failure	0.000358	0.0985	CrCbGaD
Methyldopa—ADRA2A—urethra—chronic kidney failure	0.000293	0.0159	CbGeAlD
Methyldopa—ADRA2A—cortex of kidney—chronic kidney failure	0.000281	0.0152	CbGeAlD
Methyldopa—ADRA2A—gonad—chronic kidney failure	0.000267	0.0145	CbGeAlD
Methyldopa—ADRA2A—blood—chronic kidney failure	0.000233	0.0127	CbGeAlD
Methyldopa—Norepinephrine—SLC22A2—chronic kidney failure	0.000223	0.0615	CrCbGaD
Methyldopa—Dopamine—SLC22A2—chronic kidney failure	0.000208	0.0572	CrCbGaD
Methyldopa—Epinephrine—SLC22A2—chronic kidney failure	0.000203	0.0558	CrCbGaD
Methyldopa—Aminosalicylic Acid—PTGS1—chronic kidney failure	0.000161	0.0444	CrCbGaD
Methyldopa—Mesalazine—PTGS1—chronic kidney failure	0.000126	0.0348	CrCbGaD
Methyldopa—L-DOPA—DRD1—chronic kidney failure	0.00011	0.0302	CrCbGaD
Methyldopa—Dopamine—DRD1—chronic kidney failure	0.000102	0.0281	CrCbGaD
Methyldopa—Aminosalicylic Acid—PTGS2—chronic kidney failure	9.21e-05	0.0254	CrCbGaD
Methyldopa—Epinephrine—TNF—chronic kidney failure	8.76e-05	0.0241	CrCbGaD
Methyldopa—Isoprenaline—CYP1A1—chronic kidney failure	7.93e-05	0.0218	CrCbGaD
Methyldopa—COMT—Biological oxidations—POMC—chronic kidney failure	7.57e-05	0.00247	CbGpPWpGaD
Methyldopa—Mesalazine—PTGS2—chronic kidney failure	7.23e-05	0.0199	CrCbGaD
Methyldopa—COMT—Metabolism—FABP1—chronic kidney failure	7.14e-05	0.00233	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ACAT1—chronic kidney failure	6.97e-05	0.00227	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—SERPINE1—chronic kidney failure	6.87e-05	0.00224	CbGpPWpGaD
Methyldopa—Dopamine—CYP2C19—chronic kidney failure	6.85e-05	0.0189	CrCbGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—IL1B—chronic kidney failure	6.84e-05	0.00223	CbGpPWpGaD
Methyldopa—COMT—Metabolism—AGXT—chronic kidney failure	6.76e-05	0.00221	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GATM—chronic kidney failure	6.76e-05	0.00221	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—AVP—chronic kidney failure	6.65e-05	0.00217	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MLXIPL—chronic kidney failure	6.48e-05	0.00211	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—GCKR—chronic kidney failure	6.43e-05	0.0021	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—ABCC3—chronic kidney failure	6.43e-05	0.0021	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—NFKB1—chronic kidney failure	6.38e-05	0.00208	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ACAT1—chronic kidney failure	6.19e-05	0.00202	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—ABCC2—chronic kidney failure	6.17e-05	0.00201	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—OLR1—chronic kidney failure	6.06e-05	0.00198	CbGpPWpGaD
Methyldopa—DDC—Metabolism—SLC22A2—chronic kidney failure	5.92e-05	0.00193	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—VEGFA—chronic kidney failure	5.79e-05	0.00189	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MLXIPL—chronic kidney failure	5.75e-05	0.00188	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ABCG1—chronic kidney failure	5.51e-05	0.0018	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PIP5K1B—chronic kidney failure	5.39e-05	0.00176	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—NPY—chronic kidney failure	5.33e-05	0.00174	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ARG2—chronic kidney failure	5.28e-05	0.00172	CbGpPWpGaD
Methyldopa—COMT—Metabolism—SLC22A2—chronic kidney failure	5.26e-05	0.00172	CbGpPWpGaD
Methyldopa—DDC—Metabolism—LCAT—chronic kidney failure	5.18e-05	0.00169	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SLC7A9—chronic kidney failure	5.02e-05	0.00164	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—TNF—chronic kidney failure	4.96e-05	0.00162	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ABCG1—chronic kidney failure	4.89e-05	0.0016	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PIP5K1B—chronic kidney failure	4.79e-05	0.00156	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ARG2—chronic kidney failure	4.69e-05	0.00153	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CYP2B6—chronic kidney failure	4.62e-05	0.00151	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PRKAG2—chronic kidney failure	4.62e-05	0.00151	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PRKD1—chronic kidney failure	4.62e-05	0.00151	CbGpPWpGaD
Methyldopa—COMT—Metabolism—LCAT—chronic kidney failure	4.6e-05	0.0015	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD1—chronic kidney failure	4.44e-05	0.00145	CbGpPWpGaD
Methyldopa—DDC—Metabolism—SREBF2—chronic kidney failure	4.32e-05	0.00141	CbGpPWpGaD
Methyldopa—Epinephrine—CYP3A4—chronic kidney failure	4.25e-05	0.0117	CrCbGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPY—chronic kidney failure	4.24e-05	0.00138	CbGpPWpGaD
Methyldopa—COMT—Metabolism—DDC—chronic kidney failure	4.22e-05	0.00138	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GCKR—chronic kidney failure	4.17e-05	0.00136	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ABCC3—chronic kidney failure	4.17e-05	0.00136	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PRKD1—chronic kidney failure	4.1e-05	0.00134	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PRKAG2—chronic kidney failure	4.1e-05	0.00134	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CYP2B6—chronic kidney failure	4.1e-05	0.00134	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OXT—chronic kidney failure	4.09e-05	0.00133	CbGpPWpGaD
Methyldopa—DDC—Metabolism—LPIN1—chronic kidney failure	4.08e-05	0.00133	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CRHR1—chronic kidney failure	4.06e-05	0.00133	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—ALB—chronic kidney failure	4.03e-05	0.00131	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—IL6—chronic kidney failure	4e-05	0.00131	CbGpPWpGaD
Methyldopa—DDC—Metabolism—LRP2—chronic kidney failure	4e-05	0.00131	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CYP2C18—chronic kidney failure	4e-05	0.00131	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—chronic kidney failure	3.88e-05	0.00126	CbGpPWpGaD
Methyldopa—COMT—Metabolism—SREBF2—chronic kidney failure	3.84e-05	0.00125	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—chronic kidney failure	3.8e-05	0.00124	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—PTH—chronic kidney failure	3.72e-05	0.00121	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ABCC3—chronic kidney failure	3.71e-05	0.00121	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GCKR—chronic kidney failure	3.71e-05	0.00121	CbGpPWpGaD
Methyldopa—COMT—Metabolism—LPIN1—chronic kidney failure	3.63e-05	0.00118	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CYP2C18—chronic kidney failure	3.55e-05	0.00116	CbGpPWpGaD
Methyldopa—COMT—Metabolism—LRP2—chronic kidney failure	3.55e-05	0.00116	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CPT1A—chronic kidney failure	3.4e-05	0.00111	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—AVP—chronic kidney failure	3.38e-05	0.0011	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—CCL5—chronic kidney failure	3.33e-05	0.00109	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CYP2C19—chronic kidney failure	3.32e-05	0.00108	CbGpPWpGaD
Methyldopa—DDC—Metabolism—LIPC—chronic kidney failure	3.32e-05	0.00108	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	3.27e-05	0.00107	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—IL6—chronic kidney failure	3.27e-05	0.00107	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—NPY—chronic kidney failure	3.23e-05	0.00105	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CRH—chronic kidney failure	3.11e-05	0.00102	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—OXT—chronic kidney failure	3.11e-05	0.00102	CbGpPWpGaD
Methyldopa—DDC—Metabolism—SCARB1—chronic kidney failure	3.06e-05	0.001	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PTGS1—chronic kidney failure	3.03e-05	0.000989	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CPT1A—chronic kidney failure	3.02e-05	0.000986	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—CCR5—chronic kidney failure	3e-05	0.000978	CbGpPWpGaD
Methyldopa—DDC—Metabolism—SREBF1—chronic kidney failure	2.97e-05	0.00097	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—NPS—chronic kidney failure	2.95e-05	0.000963	CbGpPWpGaD
Methyldopa—COMT—Metabolism—LIPC—chronic kidney failure	2.94e-05	0.000961	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CYP2C19—chronic kidney failure	2.94e-05	0.000961	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—DRD1—chronic kidney failure	2.89e-05	0.000944	CbGpPWpGaD
Methyldopa—DDC—Metabolism—HMGCR—chronic kidney failure	2.89e-05	0.000944	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—FABP1—chronic kidney failure	2.84e-05	0.000925	CbGpPWpGaD
Methyldopa—DDC—Metabolism—FASN—chronic kidney failure	2.83e-05	0.000924	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AVP—chronic kidney failure	2.8e-05	0.000914	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR5—chronic kidney failure	2.78e-05	0.000907	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—PPARA—chronic kidney failure	2.75e-05	0.000899	CbGpPWpGaD
Methyldopa—COMT—Metabolism—SCARB1—chronic kidney failure	2.72e-05	0.000887	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—F2—chronic kidney failure	2.7e-05	0.000881	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PTGS1—chronic kidney failure	2.69e-05	0.000879	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—AGXT—chronic kidney failure	2.69e-05	0.000877	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GATM—chronic kidney failure	2.69e-05	0.000877	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic kidney failure	2.67e-05	0.00087	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—chronic kidney failure	2.65e-05	0.000863	CbGpPWpGaD
Methyldopa—COMT—Metabolism—SREBF1—chronic kidney failure	2.64e-05	0.000862	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CYP3A4—chronic kidney failure	2.62e-05	0.000856	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ABCA1—chronic kidney failure	2.58e-05	0.000841	CbGpPWpGaD
Methyldopa—COMT—Metabolism—HMGCR—chronic kidney failure	2.57e-05	0.000838	CbGpPWpGaD
Methyldopa—COMT—Metabolism—FASN—chronic kidney failure	2.51e-05	0.00082	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ACAT1—chronic kidney failure	2.46e-05	0.000802	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—chronic kidney failure	2.38e-05	0.000777	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IGF1—chronic kidney failure	2.37e-05	0.000772	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—POMC—chronic kidney failure	2.34e-05	0.000764	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CYP3A4—chronic kidney failure	2.33e-05	0.00076	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—NOS1—chronic kidney failure	2.31e-05	0.000753	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CRHR1—chronic kidney failure	2.3e-05	0.000749	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ABCA1—chronic kidney failure	2.29e-05	0.000747	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MLXIPL—chronic kidney failure	2.29e-05	0.000746	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—chronic kidney failure	2.25e-05	0.000733	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—ALB—chronic kidney failure	2.24e-05	0.000732	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CAT—chronic kidney failure	2.18e-05	0.000712	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—AVP—chronic kidney failure	2.13e-05	0.000696	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ABCB1—chronic kidney failure	2.12e-05	0.000693	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PTH—chronic kidney failure	2.1e-05	0.000685	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SLC22A2—chronic kidney failure	2.09e-05	0.000682	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CRHR1—chronic kidney failure	2.08e-05	0.00068	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—ALB—chronic kidney failure	2.05e-05	0.000668	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	2.04e-05	0.000667	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—EDN1—chronic kidney failure	2.03e-05	0.000662	CbGpPWpGaD
Methyldopa—DDC—Metabolism—LPL—chronic kidney failure	2.02e-05	0.00066	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCL5—chronic kidney failure	2.01e-05	0.000657	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CYP1A1—chronic kidney failure	1.95e-05	0.000638	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ABCG1—chronic kidney failure	1.94e-05	0.000634	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CAT—chronic kidney failure	1.94e-05	0.000632	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PTH—chronic kidney failure	1.91e-05	0.000622	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PIP5K1B—chronic kidney failure	1.9e-05	0.000621	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ABCB1—chronic kidney failure	1.89e-05	0.000615	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ARG2—chronic kidney failure	1.86e-05	0.000608	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	1.86e-05	0.000608	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—LCAT—chronic kidney failure	1.83e-05	0.000596	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—NPY—chronic kidney failure	1.82e-05	0.000595	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	1.82e-05	0.000594	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MTHFR—chronic kidney failure	1.82e-05	0.000594	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCR5—chronic kidney failure	1.81e-05	0.000592	CbGpPWpGaD
Methyldopa—COMT—Metabolism—LPL—chronic kidney failure	1.8e-05	0.000586	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PPARA—chronic kidney failure	1.79e-05	0.000583	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—OXT—chronic kidney failure	1.76e-05	0.000574	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CRH—chronic kidney failure	1.76e-05	0.000574	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—COL4A5—chronic kidney failure	1.75e-05	0.00057	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CYP1A1—chronic kidney failure	1.74e-05	0.000566	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—DDC—chronic kidney failure	1.68e-05	0.000547	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—NPS—chronic kidney failure	1.67e-05	0.000544	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—NPY—chronic kidney failure	1.66e-05	0.00054	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—DRD1—chronic kidney failure	1.64e-05	0.000534	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PRKAG2—chronic kidney failure	1.63e-05	0.000531	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP2B6—chronic kidney failure	1.63e-05	0.000531	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PRKD1—chronic kidney failure	1.63e-05	0.000531	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TFDP2—chronic kidney failure	1.63e-05	0.00053	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MTHFR—chronic kidney failure	1.62e-05	0.000528	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CRH—chronic kidney failure	1.6e-05	0.000521	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—OXT—chronic kidney failure	1.6e-05	0.000521	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PIP5K1B—chronic kidney failure	1.59e-05	0.000519	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PPARA—chronic kidney failure	1.59e-05	0.000518	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—F2—chronic kidney failure	1.56e-05	0.000508	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—chronic kidney failure	1.55e-05	0.000504	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SREBF2—chronic kidney failure	1.53e-05	0.000498	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—NPS—chronic kidney failure	1.51e-05	0.000494	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PLAU—chronic kidney failure	1.5e-05	0.000489	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—DRD1—chronic kidney failure	1.49e-05	0.000485	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GCKR—chronic kidney failure	1.47e-05	0.000481	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ABCC3—chronic kidney failure	1.47e-05	0.000481	CbGpPWpGaD
Methyldopa—DDC—Metabolism—POMC—chronic kidney failure	1.46e-05	0.000475	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PGF—chronic kidney failure	1.45e-05	0.000473	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—LPIN1—chronic kidney failure	1.44e-05	0.00047	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—chronic kidney failure	1.42e-05	0.000463	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—POMC—chronic kidney failure	1.42e-05	0.000463	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—LRP2—chronic kidney failure	1.41e-05	0.000461	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP2C18—chronic kidney failure	1.41e-05	0.000461	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—F2—chronic kidney failure	1.39e-05	0.000454	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCL2—chronic kidney failure	1.39e-05	0.000453	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PRKAG2—chronic kidney failure	1.36e-05	0.000444	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ALB—chronic kidney failure	1.33e-05	0.000433	CbGpPWpGaD
Methyldopa—COMT—Metabolism—POMC—chronic kidney failure	1.29e-05	0.000422	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—COL4A3—chronic kidney failure	1.29e-05	0.000421	CbGpPWpGaD
Methyldopa—DDC—Metabolism—NOS3—chronic kidney failure	1.27e-05	0.000415	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HBEGF—chronic kidney failure	1.26e-05	0.000412	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CRHR1—chronic kidney failure	1.23e-05	0.000402	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IGF1—chronic kidney failure	1.22e-05	0.000398	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—AVP—chronic kidney failure	1.21e-05	0.000393	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CPT1A—chronic kidney failure	1.2e-05	0.000392	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—LRP2—chronic kidney failure	1.18e-05	0.000385	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ALB—chronic kidney failure	1.18e-05	0.000385	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—LIPC—chronic kidney failure	1.17e-05	0.000382	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP2C19—chronic kidney failure	1.17e-05	0.000382	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PTGS2—chronic kidney failure	1.16e-05	0.000379	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SERPINE1—chronic kidney failure	1.16e-05	0.000378	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—ALB—chronic kidney failure	1.16e-05	0.000377	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—EDN1—chronic kidney failure	1.15e-05	0.000374	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CCL5—chronic kidney failure	1.14e-05	0.000371	CbGpPWpGaD
Methyldopa—COMT—Metabolism—NOS3—chronic kidney failure	1.13e-05	0.000368	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PTH—chronic kidney failure	1.13e-05	0.000368	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—NOS3—chronic kidney failure	1.11e-05	0.000361	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CYBB—chronic kidney failure	1.1e-05	0.000358	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—AVP—chronic kidney failure	1.1e-05	0.000357	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SCARB1—chronic kidney failure	1.08e-05	0.000353	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PTGS1—chronic kidney failure	1.07e-05	0.000349	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SREBF1—chronic kidney failure	1.05e-05	0.000342	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—EDN1—chronic kidney failure	1.04e-05	0.00034	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—FGF23—chronic kidney failure	1.04e-05	0.000339	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCL5—chronic kidney failure	1.03e-05	0.000337	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PTGS2—chronic kidney failure	1.03e-05	0.000337	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CCR5—chronic kidney failure	1.03e-05	0.000335	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—HMGCR—chronic kidney failure	1.02e-05	0.000333	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—FASN—chronic kidney failure	9.99e-06	0.000326	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NPY—chronic kidney failure	9.78e-06	0.000319	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—OXT—chronic kidney failure	9.44e-06	0.000308	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CRH—chronic kidney failure	9.44e-06	0.000308	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCR5—chronic kidney failure	9.31e-06	0.000304	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP3A4—chronic kidney failure	9.26e-06	0.000302	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ABCA1—chronic kidney failure	9.1e-06	0.000297	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NCF1—chronic kidney failure	9.04e-06	0.000295	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NPS—chronic kidney failure	8.95e-06	0.000292	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—F2—chronic kidney failure	8.8e-06	0.000287	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—DRD1—chronic kidney failure	8.78e-06	0.000286	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CYBA—chronic kidney failure	8.5e-06	0.000277	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—POMC—chronic kidney failure	8.01e-06	0.000261	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—F2—chronic kidney failure	7.99e-06	0.000261	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—VEGFA—chronic kidney failure	7.97e-06	0.00026	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CAT—chronic kidney failure	7.7e-06	0.000251	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ABCB1—chronic kidney failure	7.49e-06	0.000244	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HBEGF—chronic kidney failure	7.46e-06	0.000243	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—TGFB1—chronic kidney failure	7.31e-06	0.000239	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—POMC—chronic kidney failure	7.28e-06	0.000237	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—LPL—chronic kidney failure	7.14e-06	0.000233	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCL2—chronic kidney failure	7.12e-06	0.000232	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP1A1—chronic kidney failure	6.9e-06	0.000225	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—KRAS—chronic kidney failure	6.77e-06	0.000221	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AVP—chronic kidney failure	6.47e-06	0.000211	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MTHFR—chronic kidney failure	6.43e-06	0.00021	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PPARA—chronic kidney failure	6.31e-06	0.000206	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—EDN1—chronic kidney failure	6.15e-06	0.000201	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCL5—chronic kidney failure	6.11e-06	0.000199	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—LPL—chronic kidney failure	5.97e-06	0.000195	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NGF—chronic kidney failure	5.65e-06	0.000184	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCR5—chronic kidney failure	5.5e-06	0.000179	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—POMC—chronic kidney failure	5.14e-06	0.000168	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—F2—chronic kidney failure	4.72e-06	0.000154	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ALB—chronic kidney failure	4.69e-06	0.000153	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NOS3—chronic kidney failure	4.48e-06	0.000146	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IRS1—chronic kidney failure	4.46e-06	0.000146	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—POMC—chronic kidney failure	4.3e-06	0.00014	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCL2—chronic kidney failure	4.21e-06	0.000137	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IGF1—chronic kidney failure	4.14e-06	0.000135	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PTGS2—chronic kidney failure	4.1e-06	0.000134	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—SERPINE1—chronic kidney failure	3.93e-06	0.000128	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—KRAS—chronic kidney failure	3.89e-06	0.000127	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NOS3—chronic kidney failure	3.75e-06	0.000122	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—RELA—chronic kidney failure	3.53e-06	0.000115	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL6—chronic kidney failure	3.16e-06	0.000103	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NFKB1—chronic kidney failure	2.98e-06	9.71e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—VEGFA—chronic kidney failure	2.7e-06	8.81e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TGFB1—chronic kidney failure	2.48e-06	8.09e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—KRAS—chronic kidney failure	2.3e-06	7.49e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL6—chronic kidney failure	1.87e-06	6.1e-05	CbGpPWpGaD
